Implications of year 1 Trump Administration policies for Americans’ lung health
https://academic.oup.com/ajrccm/article/212/5/900/8503855
Abstractm
“In 2025, the Trump Administration undertook multiple actions with major ramifications for the pulmonary health of Americans.
The “One Big Beautiful Bill Act” (OBBBA), signed into law by President Trump on July 4, 2025, will terminate healthcare coverage for many low-income Americans with lung disease. The administration’s rollback of environmental protections and reduction in subsidies for clean energy production will worsen air quality and accelerate climate change. Cuts at the Centers for Disease Control and Prevention (CDC) could disrupt occupational health protections and tobacco and asthma control efforts; the Department of Health and Human Services (HHS) leadership’s embrace of anti-vaccine theories will drive vaccine-preventable illness. The termination of federally funded research grants, including some focused on respiratory diseases, could slow medical progress. And sweeping disruptions to global health aid may impede global tuberculosis control.
In this article, we assess the likely impacts on Americans’ pulmonary health, across the life course, of policies proposed or enacted in the first year of the second Trump Administration, drawing on peer-reviewed studies, media reporting, Congressional Budget Office (CBO) reports, government agencies’ impact analyses, and our analyses of national survey data.”
Abstractm
“In 2025, the Trump Administration undertook multiple actions with major ramifications for the pulmonary health of Americans.
The “One Big Beautiful Bill Act” (OBBBA), signed into law by President Trump on July 4, 2025, will terminate healthcare coverage for many low-income Americans with lung disease. The administration’s rollback of environmental protections and reduction in subsidies for clean energy production will worsen air quality and accelerate climate change. Cuts at the Centers for Disease Control and Prevention (CDC) could disrupt occupational health protections and tobacco and asthma control efforts; the Department of Health and Human Services (HHS) leadership’s embrace of anti-vaccine theories will drive vaccine-preventable illness. The termination of federally funded research grants, including some focused on respiratory diseases, could slow medical progress. And sweeping disruptions to global health aid may impede global tuberculosis control.
In this article, we assess the likely impacts on Americans’ pulmonary health, across the life course, of policies proposed or enacted in the first year of the second Trump Administration, drawing on peer-reviewed studies, media reporting, Congressional Budget Office (CBO) reports, government agencies’ impact analyses, and our analyses of national survey data.”
